Next Science Limited logo

Next Science Limited

ASX:NXS.AX

Overview | Financials
Company Name Next Science Limited
Symbol NXS.AX
Currency AUD
Price 0.435
Market Cap 126,887,325
Dividend Yield 0%
52-week-range 0.18 - 0.75
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Harry Thomas Hall
Website https://www.nextscience.com

An error occurred while fetching data.

About Next Science Limited

Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound

Related Stocks

Genetic Signatures Limited logo

Genetic Signatures Limited

GSS.AX

0.69 AUD

Alcidion Group Limited logo

Alcidion Group Limited

ALC.AX

0.045 AUD

Volpara Health Technologies Limited logo

Volpara Health Technologies Limited

VHT.AX

1.14 AUD

Probiotec Limited logo

Probiotec Limited

PBP.AX

2.84 AUD

Medical Developments International Limited logo

Medical Developments International Limited

MVP.AX

0.565 AUD

AVITA Medical, Inc. logo

AVITA Medical, Inc.

AVH.AX

2.8 AUD

ImpediMed Limited logo

ImpediMed Limited

IPD.AX

0.093 AUD

Healthia Limited logo

Healthia Limited

HLA.AX

1.795 AUD

Mach7 Technologies Limited logo

Mach7 Technologies Limited

M7T.AX

0.66 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD